Can you get 5 doses from a Mounjaro pen — or is that a counting error?

You're standing at the fridge, pen in hand, wondering if there's one more shot left

It's a question our prescribers hear more often than you might expect. Someone is near the end of their four-week supply, the new pen hasn't arrived yet, or they're simply curious whether the device holds a little extra. The pen feels like it still has something in it. The plunger hasn't bottomed out completely. And the instinct to check is understandable.

The answer is firm, though. According to the Mounjaro Summary of Product Characteristics on the eMC, each KwikPen is filled with enough tirzepatide for exactly four injections at the labelled strength. The device is engineered to deliver four pre-set doses and then stop. After the fourth injection, the pen locks and will not fire again, that mechanical stop is intentional, not a fault.

Some residual liquid may remain in the cartridge after the counter reaches zero. This is a standard feature of pre-filled injection pens across many medicines; it is a manufacturing overfill designed to ensure four full doses can be reliably delivered, not a bonus dose waiting to be used. If you've ever found yourself wondering whether five doses can be squeezed from a single Mounjaro pen, our dedicated page works through exactly why that isn't possible and what the residual liquid actually represents. The pen should go into your sharps container once the fourth dose is done.

If you're curious about the detail of what each strength contains and how the treatment is structured, our Mounjaro overview page covers the licensed dose range from 2.5mg through to 15mg.

Why the four-dose structure exists, and why it matters for your schedule

Tirzepatide is taken once weekly. Four doses per pen maps precisely onto a four-week supply. That alignment is deliberate: it makes stock management predictable, keeps each pen at a single calibrated strength, and makes it straightforward to track where you are in your titration schedule.

Titration (the step-by-step process of increasing your dose) is managed by your prescriber over several months. The NHS medicines information for tirzepatide describes treatment starting at 2.5mg, with the prescriber guiding increases at roughly four-week intervals based on how well you are tolerating each level. The pen structure reinforces that rhythm: one pen, one dose strength, four weeks, then a clinical re-review before the next step.

This is also why questions like whether you can skip a titration step always come back to the prescriber's assessment rather than what happens to be in your pen. The device doesn't decide your dose; the clinical evidence and your individual response do.

One practical note on storage: keeping the pen in use at room temperature is fine for a short, defined window (check your Patient Information Leaflet for the exact hours), but a spare pen waiting for next month sits in the fridge door, away from anything that could freeze it. That routine makes it easy to spot at a glance how many pens you have left before placing your next order.

When a different strength or a missed dose changes the picture

A related question comes up when someone is prescribed, say, 7.5mg but wonders whether they can extract a 5mg dose from it instead, perhaps to soften side effects or extend the supply. This is not how the pen works. Each pen is calibrated for one strength. A 7.5mg pen delivers 7.5mg per injection; it cannot be adjusted downward by the user. Our page on whether a 5mg dose can be drawn from a 7.5mg pen covers that specific scenario in full.

Missed doses are a separate matter. If you miss a weekly injection, the SmPC guidance is not to double up on the next one. What you do depends on how many days have passed, and that question belongs with your prescriber or the Patient Information Leaflet, not with any assumptions about what the pen still contains.

Some patients also ask whether moving up from 5mg to a higher strength is straightforward once their current pen is finished. The honest answer is that dose increases involve a clinical decision, not just finishing a pen. You can read more about the step from 5mg to 10mg and what that assessment typically looks like. Understanding the cost context across strengths is also worth knowing before planning your supply, since private prices do vary by dose.

What this means practically, and where your prescriber fits in

Mounjaro is a prescription-only medicine. Every pen that arrives with you has been prescribed and clinically reviewed for your specific situation. That clinical oversight doesn't stop after the first prescription; at nume, a prescriber personally reviews your case before every repeat, checking that the dose is still appropriate and that your progress is on track.

Trying to extend a pen beyond its four doses, extract a different dose from a pen calibrated for another strength, or self-adjust your schedule based on how the pen feels are all routes around that clinical layer. They're also routes that the pen itself is designed to prevent. The mechanical lock is a patient-safety feature, not an inconvenience.

If you're thinking about whether Mounjaro treatment is the right step for you, or you want to understand how the consultation process works before committing, take a look at the weight loss treatment overview. And if you have questions about your current treatment that aren't covered here, our FAQs or the aftercare team are available seven days a week.

If you'd like a prescriber to review whether you're on the right dose and the right schedule, checking your eligibility is a good place to start.